Ferrer

  • Patients
  • Healthcare professionals
  • Ethical channel
  • Join us
  • News
  • Contact
EN

Navegación principal

  • We are Ferrer
    • Ferrer for good
    • Annual reports
    • Ethics and compliance
    • Transparency
    • Management team
    • Our history
  • Great People
  • Liveable Planet
  • Collective Action
  • Science
    • R&D Strategy
    • Pipeline
    • Our technologies
    • Clinical trials
    • Expanded Access Programs
  • Our Activities
    • A global presence
    • Pharmaceuticals
    • Active ingredients (APIs)
    • Business development
    • Manufacturing and distribution
EnglishEspañolCatalàNederlandsPortuguês, PortugalČeštinaFrançaisDeutschPolski

News

All of Ferrer’s information, just a click away

  1. Home
  2. News
normal

Discover our 2023 Sustainability Report

.
Wed, 07/10/2024 - 09:48

Ferrer obtains the distribution rights of a potential treatment for Idiopathic Pulmonary Fibrosis (IPF) and Progressive Pulmonary Fibrosis (PPF)

.
Fri, 05/24/2024 - 09:34

People living with pulmonary hypertension call for better psychological support in the absence of awareness of this severe disease

.
Sun, 04/21/2024 - 21:13

Ferrer and Verge Genomics Announce Agreement to Co-Develop Clinical-Stage ALS Therapy VRG50635

.
Fri, 03/22/2024 - 10:52

CDP rates us among the leading companies in the fight against climate change

.
Tue, 02/06/2024 - 14:56

We are EcoVadis Platinum!

.
Wed, 01/31/2024 - 12:43

Ferrer reports top-line results from Phase III ADORE study in ALS

.
Wed, 01/10/2024 - 10:52

Ferrer obtains the highest LEED certification rating for its Barcelona offices

.
Fri, 12/22/2023 - 10:59

More than 1,200 Ferrer volunteers unite in a global commitment to social justice for our Days for Good

.
Wed, 10/11/2023 - 16:25

The World Health Organization includes the cardiovascular polypill developed by the Spanish National Centre for Cardiovascular Research and Ferrer in its List of Essential Medicines

.
Tue, 08/01/2023 - 10:58
  • Cargar más
For requests for interviews or information, please contact the Communications Department

CONTACT US

alternatively, please dial +34 936 003 779

See more

R&D Strategy
Business Development

Connect

  • Contact
  • Join us
  • Press

B corp

Redes sociales footer

  • Facebook
  • linkedin
  • Youtube
  • Instagram
  • Twitter

European Union - European Regional Development Fund (ERDF)

Legal footer

  • Legal Notice
  • Privacy policy
  • Cookies policy

© 2025 Copyright Grupo Ferrer Internacional, S.A. All rights reserved.

Según la legislación vigente la información que precisa ver se considera información dirigida exclusivamente al profesional sanitario.

¿Es usted profesional sanitario?